Tissue micro-RNAs associated with colorectal cancer prognosis: a systematic review

Abstract

Colorectal cancer (CRC) is a multifactorial disease commonly diagnosed worldwide, with high mortality rates. Several studies demonstrate important associations between differential expression of micro-RNAs (miRs) and the prognosis of CRC. The present study aimed to identify differentially expressed tissue miRs associated with prognostic factors in CRC patients, through a systematic review of the Literature. Using the PubMed database, Cochrane Library and Web of Science, studies published in English evaluating miRs differentially expressed in tumor tissue and significantly associated with the prognostic aspects of CRC were selected. All the included studies used RT-PCR (Taqman or SYBR Green) for miR expression analysis and the period of publication was from 2009 to 2018. A total of 115 articles accomplished the inclusion criteria and were included in the review. The studies investigated the expression of 100 different miRs associated with prognostic aspects in colorectal cancer patients. The most frequent oncogenic miRs investigated were miR-21, miR-181a, miR-182, miR-183, miR-210 and miR-224 and the hyperexpression of these miRs was associated with distant metastasis, lymph node metastasis and worse survival in patients with CRC. The most frequent tumor suppressor miRs were miR-126, miR-199b and miR-22 and the hypoexpression of these miRs was associated with distant metastasis, worse prognosis and a higher risk of disease relapse (worse disease-free survival). Specific tissue miRs are shown to be promising prognostic biomarkers in patients with CRC, given their strong association with the prognostic aspects of these tumors, however, new studies are necessary to establish the sensibility and specificity of the individual miRs in order to use them in clinical practice.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. 1.

    INCA (2017) Estimativa 2018-Incidência de câncer no Brasil. Instituto Nacional de Câncer José Alencar Gomes da Silva, Rio de Janerio, p 130

    Google Scholar 

  2. 2.

    Mayer RJ, Wolpin BM (2009) Systemic treatment of colorectal cancer. Gastroenterology 134(5):1296–1310

    Google Scholar 

  3. 3.

    Erickson BA, Olawaire AB, Adriana Bermudez ECG, DGM (2017) American Joint Committee on Cancer Staging Manual, 8th edn. Cervix uteri, pp. 649–659

  4. 4.

    Wilhelmsen M, Kring T, Jorgensen LN, Madsen MR, Jess P, Bulut O et al (2014) Determinants of recurrence after intended curative resection for colorectal cancer. Scand J Gastroenterol 49(12):1399–1408

    PubMed  Google Scholar 

  5. 5.

    Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T et al (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62(4):220–241

    PubMed  Google Scholar 

  6. 6.

    Destri GL, Rubino AS, Latino R, Giannone F, Lanteri R, Scilletta B et al (2015) Preoperative carcinoembryonic antigen and independent prognostic factor still reliable. Int Surg 100:617–625

    Google Scholar 

  7. 7.

    Pardini B, Rosa F, Naccarati A, Vymetalkova V, Ye Y, Wu X et al (2015) Polymorphisms in microRNA genes as predictors of clinical outcomes in colorectal cancer patients. Carcinogenesis 36(1):82–86

    CAS  PubMed  Google Scholar 

  8. 8.

    Hansen TF, Christensen RDP, Andersen RF, Sørensen FB, Johnsson A, Jakobsen A (2013) MicroRNA-126 and epidermal growth factor-like domain 7-an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial. Br J Cancer 109(5):1243–1251

    CAS  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Rasmussen MH, Jensen NF, Tarpgaard LS, Qvortrup C, Rømer MU, Stenvang J et al (2013) High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer. Mol Oncol 7(3):1–10

    Google Scholar 

  10. 10.

    Masuda T, Hayashi N, Kuroda Y, Ito S, Educhi H, Mimori K (2017) MicroRNAs as biomarkers in colorectal cancer. Cancers 9(124):1–15

    Google Scholar 

  11. 11.

    Toiyama Y, Hur K, Tanaka K, Inoue Y, Kusunoki M, Boland CR et al (2014) Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer. Ann Surg 259(4):735–743

    PubMed  PubMed Central  Google Scholar 

  12. 12.

    Gregory RI, Shiekhattar R, Gregory RI, Shiekhattar R (2005) MicroRNA biogenesis and cancer. Cancer 9:3509–3512

    Google Scholar 

  13. 13.

    Hammond SM (2015) An overview of microRNAs. Adv Drug Deliv Rev 87:3–14

    CAS  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Falzone L, Scola L, Zanghì A, Biondi A, Di CA, Libra M et al (2018) Integrated analysis of colorectal cancer microRNA datasets: identification of microRNAs associated with tumor development. Aging 10(5):1000–1014

    PubMed  PubMed Central  Google Scholar 

  15. 15.

    Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J et al (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425(6956):415–419

    CAS  PubMed  Google Scholar 

  16. 16.

    MacFarlane L-A, Murphy R (2010) MicroRNA: biogenesis, function and role in cancer. Curr Genom 11(7):537–561

    CAS  Google Scholar 

  17. 17.

    Jonas S, Izaurralde E (2015) Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet 16(7):421–433. https://doi.org/10.1038/nrg3965

    CAS  Article  PubMed  Google Scholar 

  18. 18.

    Moutinho C, Esteller M (2017) MicroRNAs and epigenetics. Adv Cancer Res 135:189–220. https://doi.org/10.1016/bs.acr.2017.06.003

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6(11):857–866

    CAS  PubMed  Google Scholar 

  20. 20.

    Zhang B, Pan X, Cobb GP, Anderson TA (2007) MicroRNAs as oncogenes and tumor suppressors. Dev Biol 302(1):1–12

    CAS  PubMed  Google Scholar 

  21. 21.

    Siegel R, Desantis C, Jemal A (2014) Colorectal cancer statistics. CA Cancer J Clin 64(1):104–117

    PubMed  Google Scholar 

  22. 22.

    Xi Y, Formentini A, Chien M, Weir DB, Russo JJ, Ju J et al (2007) Prognostic values of microRNAs in colorectal cancer. Biomark Insights 1(251):113–121

    PubMed Central  Google Scholar 

  23. 23.

    Gao S, Zhao Z-Y, Wu R, Zhang Y, Zhang Z-Y (2018) Prognostic value of microRNAs in colorectal cancer: a meta-analysis. Cancer Manag 10:907–929

    CAS  Google Scholar 

  24. 24.

    Thomas J, Ohtsuka M, Pichler M, Ling H (2015) MicroRNAs: clinical relevance in colorectal cancer. Int J Mol Sci 16(12):28063–28076

    CAS  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Michael MZ, O’Connor SM, van Holst Pellekaan NG, Young GP, James RJ (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1(12):882–891

    CAS  PubMed  Google Scholar 

  26. 26.

    Gao J, Li N, Dong Y, Li S, Xu L, Li X et al (2015) MiR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer. Oncogene 34(31):4142–4152

    CAS  PubMed  Google Scholar 

  27. 27.

    Zhou T, Zhang GJ, Zhou H, Xiao HX, Li Y (2014) Overexpression of microRNA-183 in human colorectal cancer and its clinical significance. Eur J Gastroenterol Hepatol 26(2):229–233

    CAS  PubMed  Google Scholar 

  28. 28.

    Binderup HG, Madsen JS, Helweg Heegaard NH, Houlind K, Andersen RF, Brasen CL (2018) Quantification of microRNA levels in plasma: impact of preanalytical and analytical conditions. PLoS ONE 13(7):1

    Google Scholar 

  29. 29.

    Ahmed FE, NaC A, Gouda MM, Vos PW, Bonnerup C (2018) RT-qPCR for fecal mature microRNA quantification and validation. Color Cancer Methods Protoc Methods Mol Biol 165:203–215

    Google Scholar 

  30. 30.

    Fuessel S, Lohse-Fischer A, Van DV, Solomo K, Erdmann K, Wirth MP (2018) Quantification of microRNAs in urine-derived specimens susanne. Urothelial Carcinom Methods Protoc Methods Mol Biol 1655(16):201–226

    CAS  Google Scholar 

  31. 31.

    Wentz-Hunter KK, Potashkin JA (2011) The role of miRNAs as key regulators in the neoplastic microenvironment. Mol Biol Int 2011:1–8

    Google Scholar 

  32. 32.

    Radovich M, Sood AK, Armaiz-Pena GN, Rodriguez-Aguayo C, Zhang W, Pradeep S et al (2014) Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression. Nat Commun 5(1):1–13. https://doi.org/10.1038/ncomms6202

    CAS  Article  Google Scholar 

  33. 33.

    Hennessy E, Driscoll LO (2011) MicroRNA expression analysis: techniques suitable for studies of intercellular and extracellular microRNA. Gene expression profiling: methods and protocols. Methods Mol Biol 784:99–107

    CAS  PubMed  Google Scholar 

  34. 34.

    Mima K, Nishihara R, Yang J, Dou R, Masugi Y, Shi YY et al (2016) MicroRNA MIR21 (miR-21) and PTGS2 expression in colorectal cancer and patient survival. Clin Cancer Res 22(15):3841–3848

    CAS  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Fukushima Y, Iinuma H, Tsukamoto M, Matsuda K, Hashiguchi Y (2015) Clinical significance of microRNA-21 as a biomarker in each Dukes’ stage of colorectal cancer. Oncol Rep 33(2):573–582

    CAS  PubMed  Google Scholar 

  36. 36.

    Chen T-H, Wang K-L, Liu C-N, Lee H, Lin C-C, Huang C-C et al (2013) The prognostic significance of APC gene mutation and miR-21 expression in advanced-stage colorectal cancer. Color Dis 15(11):1367–1374

    Google Scholar 

  37. 37.

    Toiyama Y, Takahashi M, Hur K, Nagasaka T, Tanaka K, Inoue Y et al (2013) Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst 105(12):849–859

    CAS  PubMed  PubMed Central  Google Scholar 

  38. 38.

    Wu Y, Song Y, Xiong Y, Wang X, Xu K, Han B et al (2017) MicroRNA-21 (Mir-21) promotes cell growth and invasion by repressing tumor suppressor PTEN in colorectal cancer. Cell Physiol Biochem 43(3):945–958

    CAS  PubMed  Google Scholar 

  39. 39.

    Shibuya H, Iinuma H, Shimada R, Horiuchi A, Watanabe T (2010) Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. Oncology 79:313–320

    CAS  PubMed  Google Scholar 

  40. 40.

    Ji D, Chen Z, Li M, Zhan T, Yao Y, Zhang Z et al (2014) MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1. Mol Cancer 13(1):86

    PubMed  PubMed Central  Google Scholar 

  41. 41.

    Nishimura J, Handa R, Yamamoto H, Tanaka F, Shibata K, Mimori K et al (2012) microRNA-181a is associated with poor prognosis of colorectal cancer. Oncol Rep 28(6):2221–2226

    CAS  PubMed  Google Scholar 

  42. 42.

    Li Z, Wang H, Xu Z, Sun Y, Han J (2016) Expression and mechanism of microRNA-181a on incidence and survival in late liver metastases of colorectal cancer. Oncol Rep 35(3):1403–1408

    CAS  PubMed  Google Scholar 

  43. 43.

    Xiao G, Tang H, Wei W, Li J, Ji L, Ge J (2014) Aberrant expression of microRNA-15a and microRNA-16 synergistically associates with tumor progression and prognosis in patients with colorectal cancer. Gastroenterol Res Pract 2014:364549

    PubMed  PubMed Central  Google Scholar 

  44. 44.

    Diamantopoulos MA, Kontos CK, Kerimis D, Papadopoulos IN, Scorilas A (2017) Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients. Clin Chem Lab Med 55(5):737–747

    CAS  PubMed  Google Scholar 

  45. 45.

    Qian J, Jiang B, Li M, Chen J, Fang M (2013) Prognostic significance of microRNA-16 expression in human colorectal cancer. World J Surg 37(12):2944–2949

    PubMed  Google Scholar 

  46. 46.

    Guo Y, Li X, Lin C, Zhang Y, Hu G, Zhou J et al (2015) MicroRNA-133b inhibits connective tissue growth factor in colorectal cancer and correlates with the clinical stage of the disease. Mol Med Rep 11(4):2805–2812

    CAS  PubMed  Google Scholar 

  47. 47.

    Ellermeier C, Vang S, Cleveland K, Durand W, Resnick MB, Brodsky AS (2014) Prognostic microRNA expression signature from examination of colorectal primary and metastatic tumors. Anticancer Res 34(8):3957–3968

    CAS  PubMed  Google Scholar 

  48. 48.

    Akçakaya P, Ekelund S, Kolosenko I, Caramuta S, Özata D, Xie H et al (2011) miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer. Int J Oncol 39(2):311–318

    PubMed  Google Scholar 

  49. 49.

    Liu Y, Zhou Y, Feng X, Yang P, Yang J, Ping A et al (2014) Low expression of microRNA-126 is associated with. Wiley Period 53:358–365

    CAS  Google Scholar 

  50. 50.

    Wang LL, Du LT, Li J, Liu YM, Qu AL, Yang YM et al (2014) Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients. World J Gastroenterol 20(32):11340–11346

    CAS  PubMed  PubMed Central  Google Scholar 

  51. 51.

    Wan TMH, Lam CSC, Ng L, Chow AKM, Wong SKM, Li HS et al (2014) The clinicopathological significance of miR-133a in colorectal cancer. Dis Mark 2014:919283

    Google Scholar 

  52. 52.

    Rapti SM, Kontos CK, Papadopoulos IN, Scorilas A (2014) Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients. Clin Chem Lab Med 52(8):1217–1227

    CAS  PubMed  Google Scholar 

  53. 53.

    Liu H, Du L, Wen Z, Yang Y, Li J, Wang L et al (2013) Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value. Int J Colorectal Dis 28(5):697–703

    PubMed  Google Scholar 

  54. 54.

    Chen Y, Song W (2018) Wnt/catenin β1/microRNA 183 predicts recurrence and prognosis of patients with colorectal cancer. Oncol Lett 15(4):4451–4456

    PubMed  PubMed Central  Google Scholar 

  55. 55.

    Cristóbal I, Caramés C, Rincón R, Manso R, Madoz-Gúrpide J, Torrejón B et al (2017) Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer. Oncotarget 8(25):40169–40180

    PubMed  Google Scholar 

  56. 56.

    Shen ZZ-LZ, Wang B, Jiang KK-WK, Ye CC-XC, Cheng C, Yan Y-CYY-CY et al (2016) Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling. Oncotarget 7(23):35092–35105

    PubMed  PubMed Central  Google Scholar 

  57. 57.

    Zhang G, Xia S, Tian H, Liu Z, Zhou T (2012) Clinical significance of miR-22 expression in patients with colorectal cancer. Med Oncol 29(5):3108–3112

    CAS  PubMed  Google Scholar 

  58. 58.

    Xia S-S, Zhang G-J, Liu Z-L, Tian H-P, He Y, Meng C-Y et al (2017) MicroRNA-22 suppresses the growth, migration and invasion of colorectal cancer cells through a Sp1 negative feedback loop. Oncotarget 8(22):36266–36278

    PubMed  PubMed Central  Google Scholar 

  59. 59.

    Adamopoulos PG, Kontos CK, Rapti SM, Papadopoulos IN, Scorilas A (2015) MiR-224 overexpression is a strong and independent prognosticator of short-term relapse and poor overall survival in colorectal adenocarcinoma. Int J Oncol 46(2):849–859

    CAS  PubMed  Google Scholar 

  60. 60.

    Liao WT, Li TT, Wang ZG, Wang SY, He MR, Ye YP et al (2013) microRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2. Clin Cancer Res 19(17):4662–4672

    CAS  PubMed  Google Scholar 

  61. 61.

    Kerimis D, Kontos CK, Christodoulou S, Papadopoulos IN, Scorilas A (2017) Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma. Clin Biochem 50(6):285–292. https://doi.org/10.1016/j.clinbiochem.2016.11.034

    CAS  Article  PubMed  Google Scholar 

  62. 62.

    Gao Y, Liu Y, Du L, Li J, Qu A, Zhang X et al (2015) Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior. Med Oncol 32(1):362

    PubMed  Google Scholar 

  63. 63.

    Nagano Y, Toiyama Y, Okugawa Y, Imaoka H, Fujikawa H, Yasuda H et al (2016) MicroRNA-7 is associated with malignant potential and poor prognosis in human colorectal cancer. Anticancer Res 36(12):6521–6526

    CAS  PubMed  Google Scholar 

  64. 64.

    Suto T, Yokobori T, Yajima R, Morita H, Fujii T, Yamaguchi S et al (2015) MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulates cetuximab sensitivity via EGFR regulation. Carcinogenesis 36(3):338–345

    CAS  PubMed  Google Scholar 

  65. 65.

    Ge J, Chen Z, Li R, Lu T, Xiao G (2014) Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancer. Cancer Cell Int 14(1):1–8

    Google Scholar 

  66. 66.

    Li H, Dai S, Zhen T, Shi H, Zhang F, Yang Y et al (2014) Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer. Eur J Cancer 50(6):1207–1221. https://doi.org/10.1016/j.ejca.2013.12.010

    CAS  Article  PubMed  Google Scholar 

  67. 67.

    Wang CJ, Zhou ZG, Wang L, Yang L, Zhou B, Gu J et al (2009) Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis Mark 26(1):27–34

    Google Scholar 

  68. 68.

    Fang L, Li H, Wang L, Hu J, Jin T, Wang J et al (2014) MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression. Oncotarget 5(10):2974–2987

    PubMed  PubMed Central  Google Scholar 

  69. 69.

    Sun HB, Chen X, Ji H, Wu T, Lu HW, Zhang Y et al (2014) MiR-494 is an independent prognostic factor and promotes cell migration and invasion in colorectal cancer by directly targeting PTEN. Int J Oncol 45(6):2486–2494

    CAS  PubMed  Google Scholar 

  70. 70.

    Zhang GJ, Li Y, Zhou H, Xiao HX, Zhou T (2014) miR-20a is an independent prognostic factor in colorectal cancer and is involved in cell metastasis. Mol Med Rep 10(1):283–291

    PubMed  Google Scholar 

  71. 71.

    Cheng D, Zhao S, Tang H, Zhang D, Sun H, Yu F et al (2016) MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4. Oncotarget 7(29):45199–45213

    PubMed  PubMed Central  Google Scholar 

  72. 72.

    Gao S-J, Chen L, Lu W, Zhang L, Wang L, Zhu H-H (2018) miR-888 functions as an oncogene and predicts poor prognosis in colorectal cancer. Oncol Lett 15:9101–9109

    PubMed  PubMed Central  Google Scholar 

  73. 73.

    Nishida N, Yokobori T, Mimori K, Sudo T, Tanaka F, Shibata K et al (2011) MicroRNA miR-125b is a prognostic marker in human colorectal cancer. Int J Oncol 38(5):1437–1443

    CAS  PubMed  Google Scholar 

  74. 74.

    Ma W, Liu B, Li J, Jiang J, Zhou R, Huang L et al (2018) MicroRNA-302c represses epithelial–mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer. Biomed Pharmacother 105:670–676. https://doi.org/10.1016/j.biopha.2018.06.025

    CAS  Article  PubMed  Google Scholar 

  75. 75.

    Tong F, Ying Y, Pan H, Zhao W, Li H, Zhan X (2018) Microrna-466 (Mir-466) functions as a tumor suppressor and prognostic factor in colorectal cancer (CRC). Bosn J Basic Med Sci 18(3):252–259

    CAS  PubMed  PubMed Central  Google Scholar 

  76. 76.

    Zhang L, Xie F, Tang C, Xu W, Ding X, Liang J (2017) miR-340 suppresses tumor growth and enhances chemosensitivity of colorectal cancer by targeting RLIP76. Eur Rev Med Pharmacol Sci 21:2875–2886

    PubMed  Google Scholar 

  77. 77.

    Stiegelbauer V, Vychytilova-Faltejskova P, Karbiener M, Pehserl AM, Reicher A, Resel M et al (2017) MiR-196b-5p regulates colorectal cancer cell migration and metastases through interaction with HOXB7 and GALNT5. Clin Cancer Res 23(17):5255–5266

    CAS  PubMed  Google Scholar 

  78. 78.

    Wen L, Li Y, Jiang Z, Zhang Y, Yang B, Han F (2017) MiR-944 inhibits cell migration and invasion by targeting MACC1 in colorectal cancer. Oncol Rep 37(6):3415–3422

    CAS  PubMed  Google Scholar 

  79. 79.

    Yan L, Qiu J, Yao J (2017) Downregulation of microRNA-30d promotes cell proliferation and invasion by targeting LRH-1 in colorectal carcinoma. Int J Mol Med 39(6):1371–1380

    CAS  PubMed  PubMed Central  Google Scholar 

  80. 80.

    He Z, Yu L, Luo S, Li M, Li J, Li Q et al (2017) miR-296 inhibits the metastasis and epithelial-mesenchymal transition of colorectal cancer by targeting S100A4. BMC Cancer 17(1):1–10

    Google Scholar 

  81. 81.

    Wang Y-X, Chen Y-R, Liu S-S, Ye Y-P, Jiao H-L, Wang S-Y et al (2016) MiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42. Oncotarget 7(51):84826–84838

    PubMed  PubMed Central  Google Scholar 

  82. 82.

    Wu L, Shi B, Huang K, Fan G (2015) MicroRNA-128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1. Oncol Rep 34(5):2797–2805

    CAS  PubMed  Google Scholar 

  83. 83.

    Liao W, Gu C, Huang A, Yao J, Sun R (2016) MicroRNA-33b inhibits tumor cell growth and is associated with prognosis in colorectal cancer patients. Clin Transl Oncol 18(5):449–456

    CAS  PubMed  Google Scholar 

  84. 84.

    Qu YL, Wang HF, Sun ZQ, Tang Y, Han XN, Yu XB et al (2015) Up-regulated miR-155-5p promotes cell proliferation, invasion and metastasis in colorectal carcinoma. Int J Clin Exp Pathol 8(6):6988–6994

    CAS  PubMed  PubMed Central  Google Scholar 

  85. 85.

    Kai Y, Qiang C, Xinxin P, Miaomiao Z, Kuailu L (2015) Decreased miR-154 expression and its clinical significance in human colorectal cancer. World J Surg Oncol 13(195):615–619. https://doi.org/10.1186/s12957-015-0607-5

    Article  Google Scholar 

  86. 86.

    Xu K, Liu X, Mao X, Xue L, Wang R, Chen L et al (2015) MicroRNA-149 suppresses colorectal cancer cell migration and invasion by directly targeting forkhead box transcription factor FOXM1. Cell Physiol Biochem 35(2):499–515

    CAS  PubMed  Google Scholar 

  87. 87.

    Wang B, Shen ZL, Gao ZD, Zhao G, Wang CY, Yang Y et al (2015) MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway. Cell Cycle 14(7):1046–1058

    CAS  PubMed  PubMed Central  Google Scholar 

  88. 88.

    Chen P, Xi Q, Wang Q, Wei P (2014) Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer. Med Oncol 31(10):1–6

    Google Scholar 

  89. 89.

    Sun ZF, Zhang Z, Liu Z, Qiu B, Liu K, Dong G (2014) MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2. Med Oncol 31(6):982

    PubMed  Google Scholar 

  90. 90.

    Yu H, Gao G, Jiang L, Guo L, Lin M, Jiao X et al (2013) Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer. Int J Clin Exp Pathol 6(12):2904–2911

    PubMed  PubMed Central  Google Scholar 

  91. 91.

    Tao Y, Ma C, Fan Q, Wang Y, Han T, Sun C (2018) MicroRNA-1296 facilitates proliferation, migration and invasion of colorectal cancer cells by targeting SFPQ. J Cancer 9(13):2317–2326

    PubMed  PubMed Central  Google Scholar 

  92. 92.

    Chen W, Tong K, Yu J (2017) MicroRNA-130a is upregulated in colorectal cancer and promotes cell growth and motility by directly targeting forkhead box F2. Mol Med Rep 16(4):5241–5248

    CAS  PubMed  PubMed Central  Google Scholar 

  93. 93.

    Rapti SM, Kontos CK, Papadopoulos IN, Scorilas A (2016) High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis. Tumor Biol 37(9):11815–11824. https://doi.org/10.1007/s13277-016-5023-0

    CAS  Article  Google Scholar 

  94. 94.

    Ma W, Yu Q, Jiang J, Du X, Huang L, Zhao L et al (2016) miR-517a is an independent prognostic marker and contributes to cell migration and invasion in human colorectal cancer. Oncol Lett 11(1):2583–2589

    CAS  PubMed  PubMed Central  Google Scholar 

  95. 95.

    Zhang GJ, Li JS, Zhou H, Xiao HX, Li Y, Zhou T (2015) MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1. J Exp Clin Cancer Res 34(1):1–11

    Google Scholar 

  96. 96.

    Perez-Carbonell L, Sinicrope FA, Alberts SR, Oberg AL, Balaguer F, Castells A et al (2015) MiR-320e is a novel prognostic biomarker in colorectal cancer. Br J Cancer 113(1):83–90. https://doi.org/10.1038/bjc.2015.168

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  97. 97.

    Liu M, Zhi Q, Wang W, Zhang Q, Fang T, Ma Q (2015) Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer. Biomed Pharmacother 69:214–220. https://doi.org/10.1016/j.biopha.2014.12.001

    CAS  Article  PubMed  Google Scholar 

  98. 98.

    Wang X, Kuang Y, Shen X, Zhou H, Chen Y, Han Y et al (2014) Evaluation of miR-720 prognostic significance in patients with colorectal cancer. Tumor Biol 36(2):719–727

    CAS  Google Scholar 

  99. 99.

    Chu D, Zheng J, Li J, Li Y, Zhang J, Zhao Q et al (2014) MicroRNA-630 is a prognostic marker for patients with colorectal cancer. Tumor Biol 35(10):9787–9792

    CAS  Google Scholar 

  100. 100.

    Qu A, Du L, Yang Y, Liu H, Li J, Wang L et al (2014) Hypoxia-inducible MiR-210 is an independent prognostic factor and contributes to metastasis in colorectal cancer. PLoS ONE 9(3):e90952

    PubMed  PubMed Central  Google Scholar 

  101. 101.

    Li X, Yang C, Wang X, Zhang J, Zhang R, Liu R (2014) The expression of miR-25 is increased in colorectal cancer and is associated with patient prognosis. Med Oncol 31(1):781

    PubMed  Google Scholar 

  102. 102.

    Qin S, Zhu Y, Ai F, Li Y, Bai B, Yao W et al (2014) MicroRNA-191 correlates with poor prognosis of colorectal carcinoma and plays multiple roles by targeting tissue inhibitor of metalloprotease 3 S. Neoplasma 61(1):27–34

    CAS  PubMed  Google Scholar 

  103. 103.

    Zhou T, Zhang G, Liu Z, Xia S, Tian H (2013) Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer. Int J Color Dis 28(11):19–24

    CAS  Google Scholar 

  104. 104.

    Wang N, Liu W (2018) Increased expression of miR-552 acts as a potential predictor biomarker for poor prognosis of colorectal cancer. Eur Rev Med Pharmacol Sci 22:412–416

    CAS  PubMed  Google Scholar 

  105. 105.

    Liu TP, Huang CC, Yeh KT, Ke TW, Wei PL, Yang JR et al (2016) Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: implications for chemotherapy. Surg Oncol 25(4):429–434. https://doi.org/10.1016/j.suronc.2016.05.016

    CAS  Article  PubMed  Google Scholar 

  106. 106.

    Mokutani Y, Uemura M, Munakata K, Okuzaki D, Haraguchi N, Takahashi H et al (2016) Down-regulation of microRNA-132 is associated with poor prognosis of colorectal cancer. Ann Surg Oncol 23:599–608

    PubMed  PubMed Central  Google Scholar 

  107. 107.

    Sun P, Sun D, Wang X, Liu T, Ma Z, Duan L (2015) miR-206 is an independent prognostic factor and inhibits tumor invasion and migration in colorectal cancer. Cancer Biomark 15(4):391–396

    CAS  PubMed  Google Scholar 

  108. 108.

    Zhang G, Zhou H, Xiao H, Li Y, Zhou T (2014) MiR-378 is an independent prognostic factor and inhibits cell growth and invasion in colorectal cancer. BMC Cancer 14(1):109. https://doi.org/10.1186/1471-2407-14-109

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  109. 109.

    Song Y, Xu Y, Wang Z, Chen Y, Yue Z, Gao P et al (2012) MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer. Int J Cancer 131(5):1042–1051

    CAS  PubMed  Google Scholar 

  110. 110.

    Bin L, Zhang M, Lixia L, Aimin Z, Hua Y, Yanhong S et al (2016) Down-regulation of miRNA-30c predicts poor prognosis in colorectal cancer patients. Rev Rom Med Lab 24(4):369–375

    Google Scholar 

  111. 111.

    Lin M, Duan B, Hu J, Yu H, Sheng H, Gao H et al (2017) Decreased expression of miR-193a-3p is associated with poor prognosis in colorectal cancer. Oncol Lett 14(1):1061–1067

    CAS  PubMed  PubMed Central  Google Scholar 

  112. 112.

    Li J, Du L, Yang Y, Wang C, Liu H, Wang L et al (2013) MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2. Cancer Lett 329(1):84–90. https://doi.org/10.1016/j.canlet.2012.10.019

    CAS  Article  PubMed  Google Scholar 

  113. 113.

    Cui BH, Hong X (2018) Mir-6852 serves as a prognostic biomarker in colorectal cancer and inhibits tumor growth and metastasis by targeting tcf7. Exp Ther Med 16(2):879–885

    PubMed  PubMed Central  Google Scholar 

  114. 114.

    Wang L, Jiang C, Li D, Ge X, Shi Z, Li C et al (2016) MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1. Oncotarget 7(3):2660–2671

    PubMed  Google Scholar 

  115. 115.

    Zhang P, Ji DB, Han HB, Shi YF, Du CZ, Gu J (2014) Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer. World J Gastroenterol 20(34):12241–12248

    CAS  PubMed  PubMed Central  Google Scholar 

  116. 116.

    Orang AV, Safaralizadeh R, Hosseinpour Feizi MA, Somi MH (2014) Diagnostic and prognostic value of miR-205 in colorectal cancer. Asian Pac J Cancer Prev 15(9):4033–4037

    PubMed  Google Scholar 

  117. 117.

    Long L, Huang G, Zhu H, Guo Y, Liu Y, Huo J (2013) Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2. J Transl Med 11(1):1–10

    Google Scholar 

  118. 118.

    Lou X, Qi X, Zhang Y, Long H, Yang J (2013) Decreased expression of microRNA-625 is associated with tumor metastasis and poor prognosis in patients with colorectal cancer. J Surg Oncol 108(4):230–235

    CAS  PubMed  Google Scholar 

  119. 119.

    Meng X, Wu J, Pan C, Wang H, Ying X, Zhou Y et al (2013) Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD. Gastroenterology 145(2):426-436.e6. https://doi.org/10.1053/j.gastro.2013.04.004

    CAS  Article  PubMed  Google Scholar 

  120. 120.

    Wang X, Wang J, Ma H, Zhang J, Zhou X (2012) Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. Med Oncol 29(34):919–927

    CAS  PubMed  Google Scholar 

  121. 121.

    Roh MS, Lee HW, Jung SB, Kim K, Lee EH, Mil P et al (2018) Expression of miR-200c and its clinicopathological significance in patients with colorectal cancer. Pathol Res Pract 214(3):350–355. https://doi.org/10.1016/j.prp.2018.01.005

    CAS  Article  PubMed  Google Scholar 

  122. 122.

    Liu D-R, Guan Q-L, Gao M-T, Jiang L, Kang H-X (2016) miR-1260b is a potential prognostic biomarker in colorectal cancer. Med Sci Monit 22:2417–2423

    CAS  PubMed  PubMed Central  Google Scholar 

  123. 123.

    Mo Z-H, Wu X-D, Li S, Fei B-Y, Zhang B (2014) Expression and clinical significance of MicroRNA-376a in colorectal cancer. Asian Pac J Cancer Prev 15(21):9265–9270

    Google Scholar 

  124. 124.

    Wan D, He S, Xie B, Xu G, Gu W, Shen C et al (2013) Aberrant expression of miR-199a-3p and its clinical significance in colorectal cancers. Med Oncol 30(1):378

    PubMed  Google Scholar 

  125. 125.

    Nishida N, Yamashita S, Mimori K, Sudo T, Tanaka F, Shibata K et al (2012) MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells. Ann Surg Oncol 19(9):3065–3071

    PubMed  Google Scholar 

  126. 126.

    Yu L, Lu Y, Han X, Zhao W, Li J, Mao J et al (2016) microRNA-140-5p inhibits colorectal cancer invasion and metastasis by targeting ADAMTS5 and IGFBP5. Stem Cell Res Ther 7(1):1–11. https://doi.org/10.1186/s13287-016-0438-5

    CAS  Article  Google Scholar 

  127. 127.

    Li W, Chang J, Wang S, Liu X, Junjie P, Huang D et al (2015) miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR. Oncotarget 6(27):24448–24462

    PubMed  PubMed Central  Google Scholar 

  128. 128.

    Ress AL, Stiegelbauer V, Winter E, Schwarzenbacher D, Kiesslich T, Lax S et al (2015) MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients. Mol Carcinog 54(11):1442–1450

    CAS  PubMed  Google Scholar 

  129. 129.

    Yamashita S, Yamamoto H, Mimori K, Nishida N, Takahashi H, Haraguchi N et al (2012) MicroRNA-372 is associated with poor prognosis in colorectal cancer. Oncology 82(4):205–212

    CAS  PubMed  Google Scholar 

  130. 130.

    Zhou C, Cui F, Li J, Wang D, Wei Y, Wu Y et al (2017) MiR-650 represses high-risk non-metastatic colorectal cancer progression via inhibition of AKT2/GSK3beta/E-cadherin pathway. Oncotarget 8(30):49534–49547

    PubMed  PubMed Central  Google Scholar 

  131. 131.

    Wang ZS, Zhong M, Bian YH, Mu YF, Qin SL, Yu MH et al (2016) MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer. Oncotarget 7(28):44266–44276

    PubMed  PubMed Central  Google Scholar 

  132. 132.

    Hibino Y, Sakamoto N, Naito Y, Goto K, Oo HZ, Sentani K et al (2015) Significance of miR-148a in colorectal neoplasia: downregulation of miR-148a contributes to the carcinogenesis and cell invasion of colorectal cancer. Pathobiology 82(5):233–241

    CAS  PubMed  Google Scholar 

  133. 133.

    Wang B, Shen ZL, Jiang KW, Zhao G, You WC, Chao YY et al (2015) MicroRNA-217 functions as a prognosis predictor and inhibits colorectal cancer cell proliferation and invasion via an AEG-1 dependent mechanism. BMC Cancer 15(1):1–11

    Google Scholar 

  134. 134.

    Inoue A, Yamamoto H, Uemura M, Nishimura J, Hata T, Takemasa I et al (2015) MicroRNA-29b is a novel prognostic marker in colorectal cancer. Ann Surg Oncol 22:1410–1418

    Google Scholar 

  135. 135.

    Yin Y, Zhang B, Wang W, Fei B, Quan C, Zhang J et al (2014) MiR-204-5p inhibits proliferation and invasion and enhances chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A. Clin Cancer Res 20(23):6187–6699

    CAS  PubMed  Google Scholar 

  136. 136.

    Song M, Yin Y, Zhang J, Zhang B, Bian Z, Quan C et al (2014) MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1. Protein Cell 5(11):851–861

    CAS  PubMed  PubMed Central  Google Scholar 

  137. 137.

    Jinushi T, Shibayama Y, Kinoshita I, Oizumi S, Jinushi M, Aota T et al (2014) Low expression levels of microRNA-124-5p correlated with poor prognosis in colorectal cancer via targeting of SMC4. Cancer Med 3(6):1544–1552

    CAS  PubMed  PubMed Central  Google Scholar 

  138. 138.

    Wang MJ, Li Y, Wang R, Wang C, Yu YY, Yang L et al (2013) Downregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancer. Int J Colorectal Dis 28(2):183–189

    PubMed  Google Scholar 

  139. 139.

    Tsiakanikas P, Kontos CK, Kerimis D, Papadopoulos IN, Scorilas A (2018) High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease. Clin Chem Lab Med 56(6):990–1000

    CAS  PubMed  Google Scholar 

  140. 140.

    Rapti SM, Kontos CK, Christodoulou S, Papadopoulos IN, Scorilas A (2017) miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value. Clin Biochem 50(16–17):918–924. https://doi.org/10.1016/j.clinbiochem.2017.06.004

    CAS  Article  PubMed  Google Scholar 

  141. 141.

    Kontos CK, Tsiakanikas P, Avgeris M, Papadopoulos IN, Scorilas A (2017) miR-15a-5p, a novel prognostic biomarker, predicting recurrent colorectal adenocarcinoma. Mol Diagnosis Ther 21(4):453–464

    CAS  Google Scholar 

  142. 142.

    Yamazaki N, Koga Y, Taniguchi H, Kojima M, Kanemitsu Y, Saito N et al (2017) High expression of miR-181c as a predictive marker of recurrence in stage II colorectal cancer. Oncotarget 8(4):6970–6983

    PubMed  Google Scholar 

  143. 143.

    Noguchi T, Toiyama Y, Kitajima T, Imaoka H, Hiro J, Saigusa S et al (2016) MiRNA-503 promotes tumor progression and is associated with early recurrence and poor prognosis in human colorectal cancer. Oncology 90(4):221–231

    CAS  PubMed  Google Scholar 

  144. 144.

    Sümbül AT, Göğebakan B, Bayram S, Batmacı CY, Öztuzcu S (2015) MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case–control study. Tumor Biol 36(12):9703–9709

    Google Scholar 

  145. 145.

    Wu LZ, Mei YY, Tao DL, Dong Z, Li WL, Zhang X et al (2014) Overexpression of miR-223 correlates with tumor metastasis and poor prognosis in patients with colorectal cancer. Med Oncol 31(11):1–5

    Google Scholar 

  146. 146.

    Yiu AJ, Yiu CY (2016) Biomarkers in colorectal cancer. Anticancer Res 36:1093–1338

    CAS  PubMed  Google Scholar 

  147. 147.

    Peng Q, Zhang X, Min M, Zou L, Shen P, Yaqun Z (2017) The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis. Oncotarget 8(27):44893–44909

    PubMed  PubMed Central  Google Scholar 

  148. 148.

    Shirafkan N, Mansoori B, Mohammadi A, Shomali N, Ghasbi M, Baradaran B (2018) MicroRNAs as novel biomarkers for colorectal cancer: new outlooks. Biomed Pharmacother 97:1319–1330. https://doi.org/10.1016/j.biopha.2017.11.046

    CAS  Article  PubMed  Google Scholar 

  149. 149.

    Chung JH, Eng C (2005) Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis. Cancer Res 65(18):8096–8100

    CAS  PubMed  Google Scholar 

  150. 150.

    Zhang B, Halder SK, Kashikar ND, Cho Y, Datta A, David L et al (2010) Anti-metastatic role of Smad4 signaling in colorectal cancer bixiang. Gastroenterology 138(3):969–980

    CAS  PubMed  Google Scholar 

  151. 151.

    Oren M, Bentwich Z, Rosenfeld N, Raver-Shapira N, Moskovits N, Spector Y et al (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26(5):731–743

    PubMed  Google Scholar 

  152. 152.

    Jones RP, Sutton PA, Evans JP, Clifford R, McAvoy A, Lewis J et al (2017) Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer. Br J Cancer 116(7):923–929. https://doi.org/10.1038/bjc.2017.37

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Igor Lopes dos Santos.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest.

Ethical approval

This article does not contain any studies with animals or humans performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 76 KB)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

dos Santos, I.L., Penna, K.G.B.D., dos Santos Carneiro, M.A. et al. Tissue micro-RNAs associated with colorectal cancer prognosis: a systematic review. Mol Biol Rep 48, 1853–1867 (2021). https://doi.org/10.1007/s11033-020-06075-1

Download citation

Keywords

  • Colorectal neoplasms
  • MicroRNA
  • Prognosis
  • Systematic review
  • Oncology